<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01643772</url>
  </required_header>
  <id_info>
    <org_study_id>OXYC09-CN-102</org_study_id>
    <nct_id>NCT01643772</nct_id>
  </id_info>
  <brief_title>OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study</brief_title>
  <official_title>OxyNorm® Capsules (Immediate-Release) PK Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mundipharma (China) Pharmaceutical Co. Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mundipharma (China) Pharmaceutical Co. Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Single Dose PK Study of OxyNorm® immediate-release capsules 5, 10, and 20mg, and a
      multiple-dose PK Study of OxyNorm® immediate-release capsules 10mg in Chinese patients with
      pain.It will be a single center, open label, randomized, oral administration study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single dose: The subjects will be randomized to receive a single dose of OxyNorm®
      immediate-release capsules 5, 10, and 20mg.

      Multiple dose: The subjects will take 3 days OxyNorm® capsule 10mg, once every 6 hours, 10mg
      per dose. In the morning of the 4th day, the subjects will take single dose of OxyNorm®
      capsule 10mg. On the 5th day, all the subjects complete the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AUC0-t and AUC0-∞ for Participants Who Received a Single Dose</measure>
    <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
    <description>To calculate AUC0-t AUC0-∞of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method.Plasma concentrations of Oxycodone Hydrochloride single dose 5mg,10mg,20mg will be analyzed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cmax,Clast for Participants Who Received a Single Dose</measure>
    <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
    <description>To calculate Cmax,Clast of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tmax,t1/2 for Participants Who Received a Single Dose</measure>
    <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
    <description>To calculate Tmax,t1/2 of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clearance Rate for Participants Who Received a Single Dose</measure>
    <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
    <description>To calculate CL of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vd for Participants Who Received a Single Dose</measure>
    <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
    <description>To calculate Apparent Distribution Volume (Vd) Vd of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ke for Participants Who Received a Single Dose</measure>
    <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
    <description>To calculate Terminal Elimination Rate (ke) of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUCss for Participants Who Received Multiple Dose</measure>
    <time_frame>Predose for the 1st, 2nd, 3rd day and predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24 post dose on the 4th day.</time_frame>
    <description>To calculate AUCss of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Css_min,Css_max and Css_av for Participants Who Received Multiple Dose</measure>
    <time_frame>Predose for the 1st, 2nd, 3rd day and predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24 post dose on the 4th day.</time_frame>
    <description>To calculate Css_min,Css_max and Css_av of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tmax,t1/2 for Participants Who Received Multiple Dose</measure>
    <time_frame>Predose for the 1st, 2nd, 3rd day and predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24 post dose on the 4th day.</time_frame>
    <description>To calculate Tmax,t1/2 of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CL for Participants Who Received Multiple Dose</measure>
    <time_frame>Predose for the 1st, 2nd, 3rd day and predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24 post dose on the 4th day.</time_frame>
    <description>To calculate Clearance rate (CL) of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fluctuation Index (DF) for Participants Who Received Multiple Dose</measure>
    <time_frame>Predose for the 1st, 2nd, 3rd day and predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24 post dose on the 4th day.</time_frame>
    <description>To calculate Fluctuation index (DF) of Drug Valley and Peak Concentration of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Single Dose)</measure>
    <time_frame>Pre-dose,post dose0-2h,post dose2-4h,post dose4-8h,post dose8-12h,post dose12-24h</time_frame>
    <description>The excretion of drugs were calculated according to the concentration and volume of drugs in urine after single dose.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cumulative Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Single Dose)</measure>
    <time_frame>post dose0-2h,post dose2-4h,post dose4-8h,post dose8-12h,post dose12-24h</time_frame>
    <description>Cumulative excretion of drugs were calculated according to the concentration and volume of drugs in urine after single dose.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Average Cumulative Excretion Rate of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Single Dose)</measure>
    <time_frame>post dose 24h</time_frame>
    <description>Average cumulative excretion rate of drugs were calculated according to the concentration and volume of drugs in urine after single dose.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Multiple Dose)</measure>
    <time_frame>Pre-dose,post dose0-2h,post dose2-4h,post dose4-8h,post dose8-12h,post dose12-24h on the 4th day</time_frame>
    <description>The excretion of drugs were calculated according to the concentration and volume of drugs in urine after multiple dose on the 4th day.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cumulative Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Mutilple Dose)</measure>
    <time_frame>post dose0-2h,post dose2-4h,post dose4-8h,post dose8-12h,post dose12-24h on the 4th day</time_frame>
    <description>Cumulative excretion of drugs were calculated according to the concentration and volume of drugs in urine after multiple dose on the 4th day .</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Oxycodone Hydrochloride 5 mg Capsules</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxycodone Hydrochloride 10 mg Capsules</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxycodone Hydrochloride 20 mg Capsules</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxycodone Hydrochloride 10 mg Capsules(multi-dose)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 4: multi-dose 4 times per day Oxycodone Hydrochloride 10mg Capsules for 3 days, and one dose on 4th day morning</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone hydrochloride</intervention_name>
    <description>The subjects will be randomized to receive either a single dose of OxyNorm® Capsules 5, 10, 20mg, or multiple-dose OxyNorm® Capsules 10 mg for 13 times.</description>
    <arm_group_label>Oxycodone Hydrochloride 10 mg Capsules</arm_group_label>
    <arm_group_label>Oxycodone Hydrochloride 10 mg Capsules(multi-dose)</arm_group_label>
    <arm_group_label>Oxycodone Hydrochloride 20 mg Capsules</arm_group_label>
    <arm_group_label>Oxycodone Hydrochloride 5 mg Capsules</arm_group_label>
    <other_name>OxyNorm® Capsules</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with pain, Multiple dose group should enroll the Patients with cancer pain;

          -  Patients aged &gt;≥30 to ≤ 60 years;

          -  Body weight ≥ 45kg, and BMI range ≥19, &lt;24;

          -  Karnofsky score ≥ 70;

          -  The results of liver function and kidney tests must meet the following criteria:
             ALT、AST is within the upper limit of normal value ranges by a factor 2, and TB、BUN、Cr
             is within the upper limit of normal value ranges by a factor 1.25;

          -  The electrocardiogram examination results are normal;

          -  Patients must have given a written informed consent prior to this trial, and have the
             capability to complete every required test.

        Exclusion Criteria:

          -  Have hypersensitivity history to any opioids;

          -  Have known hypersensitivity to any of compositions of the study drugs;

          -  Patients who are likely to have paralytic ileus or acute abdomen or to perform an
             operation on abdominal region；

          -  Patients with respiratory depression, cor pulmonale, or chronic bronchial asthma;

          -  Patients who are unable to stop taking monoamine oxidase inhibitor during this trial
             period or time lapses less than 2 weeks since drug withdrawal;

          -  Patients with hypercarbia;

          -  Patients with biliary tract diseases, pancreatitis, prostatic hypertrophy, or
             corticoadrenal insufficiency;

          -  Patients with alcoholism or drug abuse history;

          -  Positive anti-HIV or syphilis antibody test result;

          -  Patients who are pregnant, or lactating;

          -  Urine screening before study is positive for opioids, barbiturates, amphetamines,
             cocaine metabolites, methadone, diazepam and cannabinoids;

          -  Donated 400 mL or more of blood or blood products within 3 months prior to the start
             of the study, or donated 200 mL or more of blood or blood products within one month
             prior to the start of the study;

          -  Subjects who participated in a clinical research study within one month of study
             entry;

          -  Patients who are currently taking opioids.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mundipharma China Ltd.</last_name>
    <role>Study Chair</role>
    <affiliation>Mundipharma China Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Affiliated Hospital to Academy of Military Medical Science of China People's Liberation Army</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>November 17, 2011</study_first_submitted>
  <study_first_submitted_qc>July 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2012</study_first_posted>
  <results_first_submitted>January 5, 2018</results_first_submitted>
  <results_first_submitted_qc>September 24, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 21, 2019</results_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study was conducted in phase I unit in two public hospitals, the first subject took the first dose study medication on 13May2011, the last subject took the last dose on 6Jul2012.</recruitment_details>
      <pre_assignment_details>The study has a 7-days screening phase, for the subject who meet all the inclusion and exclusion criteria was dosed without run-in or wash out period.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Oxycodone Hydrochloride Single Dose(5mg)</title>
          <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
        </group>
        <group group_id="P2">
          <title>Oxycodone Hydrochloride Single Dose(10mg)</title>
          <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
        </group>
        <group group_id="P3">
          <title>Oxycodone Hydrochloride Single Dose(20mg)</title>
          <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
        </group>
        <group group_id="P4">
          <title>Oxycodone Hydrochloride Multiple Dose</title>
          <description>Group 4: multi-dose 4 times per day Oxycodone Hydrochloride 10mg Capsules for 3 days, and one dose on 4th day morning</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>PP Population</population>
      <group_list>
        <group group_id="B1">
          <title>Oxycodone Hydrochloride Single Dose(5mg)</title>
          <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
        </group>
        <group group_id="B2">
          <title>Oxycodone Hydrochloride Single Dose(10mg)</title>
          <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
        </group>
        <group group_id="B3">
          <title>Oxycodone Hydrochloride Single Dose(20mg)</title>
          <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
        </group>
        <group group_id="B4">
          <title>Oxycodone Hydrochloride Multiple Dose(10mg)</title>
          <description>Group 4: multi-dose 4 times per day Oxycodone Hydrochloride 10mg Capsules for 3 days, and one dose on 4th day morning</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="16"/>
            <count group_id="B5" value="61"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>PP population</population>
          <units>year</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="15"/>
                    <count group_id="B3" value="14"/>
                    <count group_id="B4" value="14"/>
                    <count group_id="B5" value="58"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.22" spread="4.90"/>
                    <measurement group_id="B2" value="39.63" spread="6.21"/>
                    <measurement group_id="B3" value="36.16" spread="8.68"/>
                    <measurement group_id="B4" value="48.62" spread="7.87"/>
                    <measurement group_id="B5" value="41.11" spread="8.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>PP Population</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="15"/>
                    <count group_id="B3" value="14"/>
                    <count group_id="B4" value="14"/>
                    <count group_id="B5" value="58"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <population>PP Population</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="15"/>
                    <count group_id="B3" value="14"/>
                    <count group_id="B4" value="14"/>
                    <count group_id="B5" value="58"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <population>PP Population</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>China</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="15"/>
                    <count group_id="B3" value="14"/>
                    <count group_id="B4" value="14"/>
                    <count group_id="B5" value="58"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>AUC0-t and AUC0-∞ for Participants Who Received a Single Dose</title>
        <description>To calculate AUC0-t AUC0-∞of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method.Plasma concentrations of Oxycodone Hydrochloride single dose 5mg,10mg,20mg will be analyzed.</description>
        <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
        <population>PP Population</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Single Dose 5 mg</title>
            <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O2">
            <title>Oxycodone Hydrochloride Single Dose 10 mg</title>
            <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone Hydrochloride Single Dose 20 mg</title>
            <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>AUC0-t and AUC0-∞ for Participants Who Received a Single Dose</title>
          <description>To calculate AUC0-t AUC0-∞of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method.Plasma concentrations of Oxycodone Hydrochloride single dose 5mg,10mg,20mg will be analyzed.</description>
          <population>PP Population</population>
          <units>ng*hr*ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycondone(AUC0-t)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.03" spread="14.62"/>
                    <measurement group_id="O2" value="102.10" spread="23.94"/>
                    <measurement group_id="O3" value="205.89" spread="58.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(AUC0-∞)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.38" spread="15.41"/>
                    <measurement group_id="O2" value="104.56" spread="25.16"/>
                    <measurement group_id="O3" value="210.61" spread="59.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(AUC0-t)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.85" spread="9.61"/>
                    <measurement group_id="O2" value="89.76" spread="29.13"/>
                    <measurement group_id="O3" value="163.68" spread="43.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(AUC0-∞)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.93" spread="11.09"/>
                    <measurement group_id="O2" value="99.15" spread="34.11"/>
                    <measurement group_id="O3" value="178.61" spread="46.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(AUC0-t)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="3.12" spread="0"/>
                    <measurement group_id="O3" value="3.79" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(AUC0-∞)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="3.96" spread="0"/>
                    <measurement group_id="O3" value="4.36" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(AUC0-t)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.27" spread="10.43"/>
                    <measurement group_id="O2" value="28.69" spread="26.39"/>
                    <measurement group_id="O3" value="37.64" spread="17.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(AUC0-∞)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.07" spread="11.54"/>
                    <measurement group_id="O2" value="33.31" spread="29.29"/>
                    <measurement group_id="O3" value="43.85" spread="19.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cmax,Clast for Participants Who Received a Single Dose</title>
        <description>To calculate Cmax,Clast of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
        <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
        <population>PP population</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Single Dose 5 mg</title>
            <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O2">
            <title>Oxycodone Hydrochloride Single Dose 10 mg</title>
            <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone Hydrochloride Single Dose 20 mg</title>
            <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax,Clast for Participants Who Received a Single Dose</title>
          <description>To calculate Cmax,Clast of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
          <population>PP population</population>
          <units>ng*mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycodone(Cmax)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.97" spread="2.67"/>
                    <measurement group_id="O2" value="21.14" spread="4.58"/>
                    <measurement group_id="O3" value="35.56" spread="14.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(Cmax)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.19" spread="2.15"/>
                    <measurement group_id="O2" value="11.62" spread="2.79"/>
                    <measurement group_id="O3" value="19.19" spread="5.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(Cmax)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.12"/>
                    <measurement group_id="O2" value="0.42" spread="0.20"/>
                    <measurement group_id="O3" value="0.76" spread="0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(Cmax)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.64" spread="1.52"/>
                    <measurement group_id="O2" value="1.77" spread="1.46"/>
                    <measurement group_id="O3" value="3.52" spread="1.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycodone(Clast)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="0.11"/>
                    <measurement group_id="O2" value="0.37" spread="0.20"/>
                    <measurement group_id="O3" value="0.74" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(Clast)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.32" spread="0.17"/>
                    <measurement group_id="O2" value="0.89" spread="0.51"/>
                    <measurement group_id="O3" value="1.56" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(Clast)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="0.05" spread="0"/>
                    <measurement group_id="O3" value="0.05" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(Clast)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.12"/>
                    <measurement group_id="O2" value="0.36" spread="0.28"/>
                    <measurement group_id="O3" value="0.49" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Tmax,t1/2 for Participants Who Received a Single Dose</title>
        <description>To calculate Tmax,t1/2 of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
        <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
        <population>PP popluation</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Single Dose 5 mg</title>
            <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O2">
            <title>Oxycodone Hydrochloride Single Dose 10 mg</title>
            <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone Hydrochloride Single Dose 20 mg</title>
            <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax,t1/2 for Participants Who Received a Single Dose</title>
          <description>To calculate Tmax,t1/2 of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
          <population>PP popluation</population>
          <units>hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycodone (Tmax)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.98" spread="0.43"/>
                    <measurement group_id="O2" value="0.80" spread="0.22"/>
                    <measurement group_id="O3" value="0.73" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycodone (t1/2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.42" spread="0.70"/>
                    <measurement group_id="O2" value="4.38" spread="0.57"/>
                    <measurement group_id="O3" value="4.24" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone (Tmax)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.32" spread="1.36"/>
                    <measurement group_id="O2" value="1.08" spread="0.82"/>
                    <measurement group_id="O3" value="0.98" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone (t1/2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.22" spread="1.18"/>
                    <measurement group_id="O2" value="6.63" spread="1.47"/>
                    <measurement group_id="O3" value="6.59" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(Tmax)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="0.32"/>
                    <measurement group_id="O2" value="0.87" spread="0.33"/>
                    <measurement group_id="O3" value="1.07" spread="0.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine (t1/2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="11.70" spread="0"/>
                    <measurement group_id="O3" value="7.90" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(Tmax)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.62" spread="1.38"/>
                    <measurement group_id="O2" value="1.77" spread="1.46"/>
                    <measurement group_id="O3" value="2.04" spread="1.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(t1/2)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.78" spread="1.71"/>
                    <measurement group_id="O2" value="9.17" spread="1.93"/>
                    <measurement group_id="O3" value="8.22" spread="2.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Clearance Rate for Participants Who Received a Single Dose</title>
        <description>To calculate CL of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
        <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
        <population>PP popuplation</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Single Dose 5 mg</title>
            <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O2">
            <title>Oxycodone Hydrochloride Single Dose 10 mg</title>
            <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone Hydrochloride Single Dose 20 mg</title>
            <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>Clearance Rate for Participants Who Received a Single Dose</title>
          <description>To calculate CL of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
          <population>PP popuplation</population>
          <units>L*hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycodone (CL)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.49" spread="24.45"/>
                    <measurement group_id="O2" value="101.53" spread="27.54"/>
                    <measurement group_id="O3" value="101.33" spread="25.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone (CL)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="125.78" spread="28.40"/>
                    <measurement group_id="O2" value="113.30" spread="40.85"/>
                    <measurement group_id="O3" value="119.38" spread="31.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(CL)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="2525.30" spread="0"/>
                    <measurement group_id="O3" value="4587.50" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(CL)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="443.45" spread="192.68"/>
                    <measurement group_id="O2" value="530.65" spread="368.02"/>
                    <measurement group_id="O3" value="681.64" spread="736.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Vd for Participants Who Received a Single Dose</title>
        <description>To calculate Apparent Distribution Volume (Vd) Vd of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
        <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
        <population>PP population</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Single Dose 5 mg</title>
            <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O2">
            <title>Oxycodone Hydrochloride Single Dose 10 mg</title>
            <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone Hydrochloride Single Dose 20 mg</title>
            <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>Vd for Participants Who Received a Single Dose</title>
          <description>To calculate Apparent Distribution Volume (Vd) Vd of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
          <population>PP population</population>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycodone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="568.11" spread="118.51"/>
                    <measurement group_id="O2" value="626.45" spread="115.70"/>
                    <measurement group_id="O3" value="611.17" spread="137.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1119.22" spread="312.37"/>
                    <measurement group_id="O2" value="1026.65" spread="230.16"/>
                    <measurement group_id="O3" value="1138.72" spread="335.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="42608.80" spread="0"/>
                    <measurement group_id="O3" value="52264.20" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5004.50" spread="2443.16"/>
                    <measurement group_id="O2" value="7297.56" spread="5341.91"/>
                    <measurement group_id="O3" value="7460.04" spread="5956.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>ke for Participants Who Received a Single Dose</title>
        <description>To calculate Terminal Elimination Rate (ke) of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
        <time_frame>blood sample at predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24hr post-dose.</time_frame>
        <population>PP population</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Single Dose 5 mg</title>
            <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O2">
            <title>Oxycodone Hydrochloride Single Dose 10 mg</title>
            <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone Hydrochloride Single Dose 20 mg</title>
            <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>ke for Participants Who Received a Single Dose</title>
          <description>To calculate Terminal Elimination Rate (ke) of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in single dose 5mg,10mg,20mg.</description>
          <population>PP population</population>
          <units>h^-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycodone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.03"/>
                    <measurement group_id="O2" value="0.16" spread="0.02"/>
                    <measurement group_id="O3" value="0.17" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.02"/>
                    <measurement group_id="O2" value="0.11" spread="0.02"/>
                    <measurement group_id="O3" value="0.11" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="0.06" spread="0"/>
                    <measurement group_id="O3" value="0.09" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.02"/>
                    <measurement group_id="O2" value="0.08" spread="0.02"/>
                    <measurement group_id="O3" value="0.10" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>AUCss for Participants Who Received Multiple Dose</title>
        <description>To calculate AUCss of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
        <time_frame>Predose for the 1st, 2nd, 3rd day and predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24 post dose on the 4th day.</time_frame>
        <population>PP population</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Multiple Dose</title>
            <description>Group 4: multi-dose 4 times per day Oxycodone Hydrochloride 10mg Capsules for 3 days, and one dose on 4th day morning</description>
          </group>
        </group_list>
        <measure>
          <title>AUCss for Participants Who Received Multiple Dose</title>
          <description>To calculate AUCss of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
          <population>PP population</population>
          <units>ng*hours*mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycodone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="156.03" spread="72.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122.69" spread="39.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.51" spread="1.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.56" spread="8.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Css_min,Css_max and Css_av for Participants Who Received Multiple Dose</title>
        <description>To calculate Css_min,Css_max and Css_av of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
        <time_frame>Predose for the 1st, 2nd, 3rd day and predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24 post dose on the 4th day.</time_frame>
        <population>multiple dose group has 14 subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Multiple Dose</title>
            <description>Group 4: multi-dose 4 times per day Oxycodone Hydrochloride 10mg Capsules for 3 days, and one dose on 4th day morning</description>
          </group>
        </group_list>
        <measure>
          <title>Css_min,Css_max and Css_av for Participants Who Received Multiple Dose</title>
          <description>To calculate Css_min,Css_max and Css_av of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
          <population>multiple dose group has 14 subjects</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycodone(Css_min)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.92" spread="8.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(Css_min)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.74" spread="5.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(Css_min)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(Css_min)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.18" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycodone(Css_max )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.17" spread="15.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(Css_max )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.71" spread="8.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(Css_max )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.10" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(Css_max )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.65" spread="1.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycodone(Css_av)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.01" spread="12.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(Css_av)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.44" spread="6.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(Css_av)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.75" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(Css_av)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.76" spread="1.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Tmax,t1/2 for Participants Who Received Multiple Dose</title>
        <description>To calculate Tmax,t1/2 of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
        <time_frame>Predose for the 1st, 2nd, 3rd day and predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24 post dose on the 4th day.</time_frame>
        <population>multiple dose group has 14 subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Multiple Dose</title>
            <description>Group 4: multi-dose 4 times per day Oxycodone Hydrochloride 10mg Capsules for 3 days, and one dose on 4th day morning</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax,t1/2 for Participants Who Received Multiple Dose</title>
          <description>To calculate Tmax,t1/2 of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
          <population>multiple dose group has 14 subjects</population>
          <units>hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycodone( Tmax)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.35" spread="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone( Tmax)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.51" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine( Tmax)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.49" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone( Tmax)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.86" spread="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycodone(t1/2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.07" spread="1.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(t1/2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.23" spread="1.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(t1/2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.09" spread="2.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(t1/2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.07" spread="1.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>CL for Participants Who Received Multiple Dose</title>
        <description>To calculate Clearance rate (CL) of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
        <time_frame>Predose for the 1st, 2nd, 3rd day and predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24 post dose on the 4th day.</time_frame>
        <population>multiple dose group has 14 subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Multiple Dose</title>
            <description>Group 4: multi-dose 4 times per day Oxycodone Hydrochloride 10mg Capsules for 3 days, and one dose on 4th day morning</description>
          </group>
        </group_list>
        <measure>
          <title>CL for Participants Who Received Multiple Dose</title>
          <description>To calculate Clearance rate (CL) of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
          <population>multiple dose group has 14 subjects</population>
          <units>L*hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycodone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.54" spread="24.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.66" spread="32.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2374.20" spread="597.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="773.01" spread="431.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Fluctuation Index (DF) for Participants Who Received Multiple Dose</title>
        <description>To calculate Fluctuation index (DF) of Drug Valley and Peak Concentration of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
        <time_frame>Predose for the 1st, 2nd, 3rd day and predose,15min,30min,45min,1,1.5,2,3,4,6,8,12,24 post dose on the 4th day.</time_frame>
        <population>multiple dose group has 14 subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Multiple Dose</title>
            <description>Group 4: multi-dose 4 times per day Oxycodone Hydrochloride 10mg Capsules for 3 days, and one dose on 4th day morning</description>
          </group>
        </group_list>
        <measure>
          <title>Fluctuation Index (DF) for Participants Who Received Multiple Dose</title>
          <description>To calculate Fluctuation index (DF) of Drug Valley and Peak Concentration of Oxycondone,Noroxycodone,Hydroxymorphine, Normethoxymorphone with Non-atrioventricular model method in multiple dose 10mg.</description>
          <population>multiple dose group has 14 subjects</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycodone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.11" spread="32.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.75" spread="23.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="123.95" spread="57.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.07" spread="37.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Single Dose)</title>
        <description>The excretion of drugs were calculated according to the concentration and volume of drugs in urine after single dose.</description>
        <time_frame>Pre-dose,post dose0-2h,post dose2-4h,post dose4-8h,post dose8-12h,post dose12-24h</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Single Dose 5 mg</title>
            <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O2">
            <title>Oxycodone Hydrochloride Single Dose 10 mg</title>
            <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone Hydrochloride Single Dose 20 mg</title>
            <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>The Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Single Dose)</title>
          <description>The excretion of drugs were calculated according to the concentration and volume of drugs in urine after single dose.</description>
          <units>μg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycondone(Pre-dose)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                    <measurement group_id="O3" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.69" spread="29.55"/>
                    <measurement group_id="O2" value="54.55" spread="79.39"/>
                    <measurement group_id="O3" value="108.57" spread="171.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.24" spread="72.40"/>
                    <measurement group_id="O2" value="172.38" spread="192.35"/>
                    <measurement group_id="O3" value="316.07" spread="188.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.93" spread="56.60"/>
                    <measurement group_id="O2" value="169.28" spread="268.13"/>
                    <measurement group_id="O3" value="165.45" spread="101.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.07" spread="84.81"/>
                    <measurement group_id="O2" value="78.48" spread="91.91"/>
                    <measurement group_id="O3" value="71.07" spread="76.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.30" spread="88.58"/>
                    <measurement group_id="O2" value="36.12" spread="33.66"/>
                    <measurement group_id="O3" value="67.92" spread="86.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(Pre-dose)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                    <measurement group_id="O3" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.29" spread="39.94"/>
                    <measurement group_id="O2" value="63.80" spread="83.33"/>
                    <measurement group_id="O3" value="157.75" spread="229.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.53" spread="112.06"/>
                    <measurement group_id="O2" value="346.22" spread="262.65"/>
                    <measurement group_id="O3" value="784.70" spread="390.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="153.49" spread="124.65"/>
                    <measurement group_id="O2" value="418.95" spread="527.24"/>
                    <measurement group_id="O3" value="712.81" spread="417.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139.45" spread="138.45"/>
                    <measurement group_id="O2" value="212.68" spread="170.80"/>
                    <measurement group_id="O3" value="360.37" spread="375.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.09" spread="41.21"/>
                    <measurement group_id="O2" value="128.75" spread="90.37"/>
                    <measurement group_id="O3" value="265.31" spread="400.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(Pre-dose)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                    <measurement group_id="O3" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" spread="0.65"/>
                    <measurement group_id="O2" value="0.94" spread="1.41"/>
                    <measurement group_id="O3" value="2.89" spread="4.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="1.03"/>
                    <measurement group_id="O2" value="2.52" spread="3.02"/>
                    <measurement group_id="O3" value="9.99" spread="7.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.72" spread="1.46"/>
                    <measurement group_id="O2" value="5.80" spread="12.62"/>
                    <measurement group_id="O3" value="5.85" spread="6.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.07" spread="3.39"/>
                    <measurement group_id="O2" value="2.97" spread="4.02"/>
                    <measurement group_id="O3" value="2.49" spread="2.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.31" spread="6.15"/>
                    <measurement group_id="O2" value="1.67" spread="1.86"/>
                    <measurement group_id="O3" value="2.90" spread="3.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(Pre-dose)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                    <measurement group_id="O3" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.97" spread="6.96"/>
                    <measurement group_id="O2" value="7.16" spread="11.48"/>
                    <measurement group_id="O3" value="8.53" spread="13.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.44" spread="12.78"/>
                    <measurement group_id="O2" value="23.53" spread="16.86"/>
                    <measurement group_id="O3" value="40.29" spread="33.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.15" spread="33.82"/>
                    <measurement group_id="O2" value="68.87" spread="131.24"/>
                    <measurement group_id="O3" value="39.64" spread="23.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.59" spread="30.00"/>
                    <measurement group_id="O2" value="30.17" spread="21.62"/>
                    <measurement group_id="O3" value="48.38" spread="49.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.74" spread="30.33"/>
                    <measurement group_id="O2" value="30.16" spread="34.28"/>
                    <measurement group_id="O3" value="33.76" spread="31.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cumulative Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Single Dose)</title>
        <description>Cumulative excretion of drugs were calculated according to the concentration and volume of drugs in urine after single dose.</description>
        <time_frame>post dose0-2h,post dose2-4h,post dose4-8h,post dose8-12h,post dose12-24h</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Single Dose 5 mg</title>
            <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O2">
            <title>Oxycodone Hydrochloride Single Dose 10 mg</title>
            <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone Hydrochloride Single Dose 20 mg</title>
            <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>Cumulative Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Single Dose)</title>
          <description>Cumulative excretion of drugs were calculated according to the concentration and volume of drugs in urine after single dose.</description>
          <units>μg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycondone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.69" spread="29.55"/>
                    <measurement group_id="O2" value="54.55" spread="79.39"/>
                    <measurement group_id="O3" value="108.57" spread="171.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.93" spread="91.36"/>
                    <measurement group_id="O2" value="226.92" spread="244.12"/>
                    <measurement group_id="O3" value="424.64" spread="326.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="154.86" spread="129.52"/>
                    <measurement group_id="O2" value="396.20" spread="410.41"/>
                    <measurement group_id="O3" value="590.08" spread="361.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="210.92" spread="203.25"/>
                    <measurement group_id="O2" value="474.68" spread="455.83"/>
                    <measurement group_id="O3" value="661.15" spread="338.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="251.22" spread="198.78"/>
                    <measurement group_id="O2" value="510.80" spread="462.41"/>
                    <measurement group_id="O3" value="729.07" spread="343.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.29" spread="39.94"/>
                    <measurement group_id="O2" value="63.80" spread="83.33"/>
                    <measurement group_id="O3" value="157.75" spread="229.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128.82" spread="117.04"/>
                    <measurement group_id="O2" value="410.02" spread="283.62"/>
                    <measurement group_id="O3" value="942.44" spread="529.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="282.31" spread="192.38"/>
                    <measurement group_id="O2" value="828.97" spread="629.00"/>
                    <measurement group_id="O3" value="1655.25" spread="736.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="421.75" spread="222.63"/>
                    <measurement group_id="O2" value="1041.66" spread="699.41"/>
                    <measurement group_id="O3" value="2015.62" spread="865.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="474.85" spread="232.06"/>
                    <measurement group_id="O2" value="1170.41" spread="703.51"/>
                    <measurement group_id="O3" value="2280.92" spread="936.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" spread="0.65"/>
                    <measurement group_id="O2" value="0.94" spread="1.41"/>
                    <measurement group_id="O3" value="2.89" spread="4.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.54" spread="1.56"/>
                    <measurement group_id="O2" value="3.46" spread="3.79"/>
                    <measurement group_id="O3" value="12.88" spread="10.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.27" spread="2.47"/>
                    <measurement group_id="O2" value="9.27" spread="13.89"/>
                    <measurement group_id="O3" value="18.73" spread="15.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.33" spread="4.83"/>
                    <measurement group_id="O2" value="12.24" spread="16.33"/>
                    <measurement group_id="O3" value="21.22" spread="15.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.64" spread="6.81"/>
                    <measurement group_id="O2" value="13.91" spread="17.13"/>
                    <measurement group_id="O3" value="24.11" spread="15.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.97" spread="6.96"/>
                    <measurement group_id="O2" value="7.16" spread="11.48"/>
                    <measurement group_id="O3" value="8.53" spread="13.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.40" spread="18.45"/>
                    <measurement group_id="O2" value="30.68" spread="19.15"/>
                    <measurement group_id="O3" value="48.82" spread="40.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.55" spread="44.62"/>
                    <measurement group_id="O2" value="99.55" spread="143.15"/>
                    <measurement group_id="O3" value="88.46" spread="53.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.14" spread="58.19"/>
                    <measurement group_id="O2" value="129.72" spread="154.63"/>
                    <measurement group_id="O3" value="136.84" spread="65.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.87" spread="76.02"/>
                    <measurement group_id="O2" value="159.88" spread="184.11"/>
                    <measurement group_id="O3" value="170.60" spread="74.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Average Cumulative Excretion Rate of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Single Dose)</title>
        <description>Average cumulative excretion rate of drugs were calculated according to the concentration and volume of drugs in urine after single dose.</description>
        <time_frame>post dose 24h</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Single Dose 5 mg</title>
            <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O2">
            <title>Oxycodone Hydrochloride Single Dose 10 mg</title>
            <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone Hydrochloride Single Dose 20 mg</title>
            <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>Average Cumulative Excretion Rate of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Single Dose)</title>
          <description>Average cumulative excretion rate of drugs were calculated according to the concentration and volume of drugs in urine after single dose.</description>
          <units>% of ug</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycondone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.02" spread="3.98"/>
                    <measurement group_id="O2" value="5.11" spread="4.62"/>
                    <measurement group_id="O3" value="3.65" spread="1.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.50" spread="4.64"/>
                    <measurement group_id="O2" value="11.70" spread="7.04"/>
                    <measurement group_id="O3" value="11.40" spread="4.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.14"/>
                    <measurement group_id="O2" value="0.14" spread="0.17"/>
                    <measurement group_id="O3" value="0.12" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.00" spread="1.52"/>
                    <measurement group_id="O2" value="1.60" spread="1.84"/>
                    <measurement group_id="O3" value="0.85" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Multiple Dose)</title>
        <description>The excretion of drugs were calculated according to the concentration and volume of drugs in urine after multiple dose on the 4th day.</description>
        <time_frame>Pre-dose,post dose0-2h,post dose2-4h,post dose4-8h,post dose8-12h,post dose12-24h on the 4th day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Multiple Dose 10 mg</title>
            <description>Group 2: multiple dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>The Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Multiple Dose)</title>
          <description>The excretion of drugs were calculated according to the concentration and volume of drugs in urine after multiple dose on the 4th day.</description>
          <units>μg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycondone(Pre-dose)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="745.99" spread="1106.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="263.32" spread="236.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="342.64" spread="301.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="431.70" spread="532.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137.13" spread="107.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="344.15" spread="516.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(Pre-dose)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="897.44" spread="1121.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="372.51" spread="290.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="438.24" spread="218.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="515.39" spread="423.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="500.42" spread="717.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="865.37" spread="861.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(Pre-dose)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.43" spread="10.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.13" spread="8.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.03" spread="59.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.52" spread="27.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.10" spread="17.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.73" spread="36.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(Pre-dose)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="337.01" spread="460.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="130.63" spread="100.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="208.27" spread="183.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="262.56" spread="382.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102.36" spread="91.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="240.75" spread="332.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cumulative Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Mutilple Dose)</title>
        <description>Cumulative excretion of drugs were calculated according to the concentration and volume of drugs in urine after multiple dose on the 4th day .</description>
        <time_frame>post dose0-2h,post dose2-4h,post dose4-8h,post dose8-12h,post dose12-24h on the 4th day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone Hydrochloride Single Dose 10 mg</title>
            <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
          </group>
        </group_list>
        <measure>
          <title>Cumulative Excretion of Oxycondone, Noroxycodone, Hydroxymorphine,Normethoxymorphone in Urine(Mutilple Dose)</title>
          <description>Cumulative excretion of drugs were calculated according to the concentration and volume of drugs in urine after multiple dose on the 4th day .</description>
          <units>μg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxycondone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="263.32" spread="236.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="605.96" spread="479.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1037.66" spread="985.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="913.59" spread="374.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxycondone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1290.63" spread="720.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="372.51" spread="290.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="810.75" spread="419.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1326.14" spread="645.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1693.83" spread="978.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Noroxycodone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2618.44" spread="1237.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.13" spread="8.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.16" spread="64.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.68" spread="67.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.85" spread="72.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxymorphine(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="108.81" spread="77.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose0-2h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="130.63" spread="100.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose2-4h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="338.90" spread="241.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose4-8h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="601.46" spread="566.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose8-12h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="575.47" spread="287.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normethoxymorphone(post dose12-24h)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="796.81" spread="518.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Single dose group the screening period is maximal 7 days, then 1 day dosing and sampling following by 1 day safety follow up, so total 9 days maximal. Multiple dose group the screening period is maximal 7 days, then 4 days dosing and sampleing following by 1 day safety follow up, so total 12 days maximal.</time_frame>
      <desc>No difference with the clinicaltrials.gov definition</desc>
      <group_list>
        <group group_id="E1">
          <title>Oxycodone Hydrochloride Single Dose(5mg)</title>
          <description>Group 1: single dose Oxycodone Hydrochloride 5 mg Capsules after 10 hours fasting</description>
        </group>
        <group group_id="E2">
          <title>Oxycodone Hydrochloride Single Dose(10mg)</title>
          <description>Group 2: single dose Oxycodone Hydrochloride 10 mg Capsules after 10 hours fasting</description>
        </group>
        <group group_id="E3">
          <title>Oxycodone Hydrochloride Single Dose(20mg)</title>
          <description>Group 3: single dose Oxycodone Hydrochloride 20 mg Capsules after 10 hours fasting</description>
        </group>
        <group group_id="E4">
          <title>Oxycodone Hydrochloride Multiple Dose(10mg)</title>
          <description>Group 4: multi-dose 4 times per day Oxycodone Hydrochloride 10mg Capsules for 3 days, and one dose on 4th day morning</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="15"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="15"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="15"/>
                <counts group_id="E4" events="7" subjects_affected="6" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="15"/>
                <counts group_id="E3" events="14" subjects_affected="14" subjects_at_risk="15"/>
                <counts group_id="E4" events="5" subjects_affected="4" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Drowsiness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ms. Dan Zhu, Clinical operation and quality lead of the study</name_or_title>
      <organization>Mundipharma (China) Pharmaceutical Co.Ltd</organization>
      <phone>+8610 6563 6891</phone>
      <email>dan.zhu@mundipharma.com.cn</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

